MediMix Oncology
  • Home
  • Congresses
    • 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • ESMO GI 2025
      • ASCO 2025
      • EADO 2025
      • ELCC 2025
      • ENETS 2025
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Webinars
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
EADO 2025

Modern imaging of actinic skin damage

22 April 2025

Presented by Prof Dr Mariano Suppa (HUBruxelles, Belgium)

Prof Dr Mariano Suppa, Associate Professor of Dermatology at Université Libre de Bruxelles, presented two interconnected topics at EADO 2025: new imaging devices for epithelial tumours and modern imaging of actinic skin damage.

He focused on a promising technology called LC-OCT (Line Field Confocal Optical Coherence Tomography), which combines the high resolution of confocal microscopy with the deep tissue penetration of OCT. This device allows high-quality in vivo imaging of epithelial tumours like basal cell carcinoma (BCC) and actinic keratosis, aiding both in diagnosis and treatment monitoring.

LC-OCT helps clinicians non-invasively assess treatment outcomes—whether after topical therapies or surgery—and can guide surgical planning by defining lesion margins more precisely. Additionally, the integration of artificial intelligence enhances the device’s capabilities by quantifying microscopic skin features such as dermal-epidermal junction undulation and epidermal cell atypia. This has potential applications beyond cancer diagnosis, including the study of field cancerisation and skin ageing, with possible relevance in dermato-aesthetic research.

Prof Dr Suppa hopes to present further updates at the next EADO Congress in 2026.

Back to EADO 2025

You may also be interested in:

ELCC 2024 Daily highlight 2

Episode 19: Relugolix as hormone therapy for men with advanced prostate cancer: results from the HERO trial

COCOON study

Tags:

in-depth

Share Article

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Congresses
    • 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • ESMO GI 2025
      • ASCO 2025
      • EADO 2025
      • ELCC 2025
      • ENETS 2025
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Webinars
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.